ArticleThe Journal of clinical investigation2017
Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression.
Liang Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
100 papers cite itlatest 60 shown
this papercites it